Omid Nikoubashman Selected Research

Contraindications

3/2016

Risk profile and treatment options of acute ischemic in-hospital stroke.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Omid Nikoubashman Research Topics

Disease

31	Stroke (Strokes) 08/2022 - 12/2014
18	Ischemic Stroke 09/2022 - 01/2014
5	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 04/2022 - 10/2015
3	Disease Progression 07/2022 - 01/2021
3	Hypertension (High Blood Pressure) 01/2022 - 01/2021
3	Hemorrhage 09/2021 - 04/2017
2	Infarction (Infarctions) 08/2022 - 01/2021
2	Inflammation (Inflammations) 01/2022 - 11/2021
2	Cerebral Infarction 01/2019 - 09/2018
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 09/2018 - 03/2016
2	Thrombosis (Thrombus) 03/2017 - 02/2017
2	Aneurysm (Aneurysms) 07/2015 - 02/2013
1	Respiratory Insufficiency (Respiratory Failure) 09/2022
1	COVID-19 09/2022
1	Embolism (Embolus) 08/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2022
1	Demyelinating Diseases (Demyelinating Disease) 11/2021
1	Spinal Cord Injuries (Spinal Cord Injury) 11/2021
1	Wounds and Injuries (Trauma) 11/2021
1	Reperfusion Injury 09/2021
1	Posterior Leukoencephalopathy Syndrome 02/2021
1	Brain Ischemia (Cerebral Ischemia) 02/2021
1	Foreign Bodies (Foreign Body) 01/2021
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2020
1	Vertebrobasilar Insufficiency 03/2018
1	Neoplasms (Cancer) 01/2018
1	Glioma (Gliomas) 01/2018
1	Hemosiderosis 10/2015
1	Intracranial Aneurysm (Cerebral Aneurysm) 02/2013

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 04/2022 - 01/2022
2	SiliconesIBA 01/2022 - 08/2019
1	Nimodipine (Modus)FDA LinkGeneric 01/2022
1	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2022
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	InflammasomesIBA 11/2021
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 11/2021
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2021
1	Therapeutic UsesIBA 11/2021
1	Interleukin-1beta (Interleukin 1 beta)IBA 11/2021
1	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 09/2021
1	Tirofiban (Aggrastat)FDA Link 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Contrast MediaIBA 01/2021
1	Protons (Proton)IBA 01/2018
1	Choline (Choline Chloride)IBA 01/2018
1	Amino Acids FDA Link 01/2018
1	N-acetylaspartate (N-acetyl aspartate)IBA 01/2018
1	PlatinumIBA 01/2016
1	HemosiderinIBA 10/2015

Therapy/Procedure

23	Thrombectomy 09/2022 - 01/2014
18	Therapeutics 04/2022 - 02/2013
9	Stents 07/2019 - 02/2013
3	Drug Tapering 01/2018 - 12/2015
2	Punctures 09/2022 - 09/2018
2	Endovascular Procedures 01/2019 - 09/2018
1	Endarterectomy (Thromboendarterectomy) 08/2022
1	Operative Surgical Procedures 08/2022
1	Catheters 04/2022
1	Carotid Endarterectomy 09/2021
1	Embolectomy 01/2021
1	Conservative Treatment 03/2018
1	Length of Stay 03/2016
1	Contraindications 03/2016
1	Microspheres (Microsphere) 07/2015